Disease-specific quality indicators, guidelines, and outcome measures in vasculitis.

Disease-specific quality indicators, guidelines, and outcome measures in vasculitis.

Measuring quality of care in the anti neutrophil cytoplasm antibody (ANCA) associated vasculitides (AAV) has become more complex, because the introduction of immunosuppressive therapy has resulted in a substantial improvement in survival. Early diagnosis remains a problem, because many patients are...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Mukhtyar, C, Luqmani, R
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	2007

Gelijkaardige items

Using the Birmingham vasculitis activity score (BVAS) to screen for vasculitis
door: Mukhtyar, C, et al.
Gepubliceerd in: (2008)

Eular recommendations for vasculitis
door: Luqmani, R, et al.
Gepubliceerd in: (2007)

Cardiovascular outcomes in ANCA associated vasculitis
door: Mukhtyar, C, et al.
Gepubliceerd in: (2008)

Why we need guidelines for clinical trials in vasculitis and systemic lupus erythematosus.
door: Mukhtyar, C, et al.
Gepubliceerd in: (2007)

Cardiovascular involvement in primary systemic vasculitis.
door: Mukhtyar, C, et al.
Gepubliceerd in: (2009)

Using the Birmingham Vasculitis Activity Score (BVAS) for diagnosing vasculitis
door: Luqmani, R, et al.
Gepubliceerd in: (2009)

USING THE BIRMINGHAM VASCULITIS ACTIVITY SCORE (VERSION 3) FOR DIAGNOSING VASCULITIS
door: Mukhtyar, C, et al.
Gepubliceerd in: (2009)

Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
door: Mukhtyar, C, et al.
Gepubliceerd in: (2008)

Outpatient assessment of systemic vasculitis.
door: Nataraja, A, et al.
Gepubliceerd in: (2007)

Outcome measures in ANCA-associated vasculitis.
door: Suppiah, R, et al.
Gepubliceerd in: (2010)

The role of biologic therapies in the management of systemic vasculitis.
door: Chan, A, et al.
Gepubliceerd in: (2006)

Current evidence of factors influencing remission, relapse, renal failure and mortality in patients with systemic vasculitis. A systematic review for the EULAR systemic vasculitis task force
door: Mukhtyar, C, et al.
Gepubliceerd in: (2007)

Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
door: Mukhtyar, C, et al.
Gepubliceerd in: (2006)

The vasculitis damage index as a surrogate outcome measure in systemic vasculitis.
door: McRorie, E, et al.
Gepubliceerd in: (1997)

Outcome in systemic vasculitis.
door: Luqmani, R, et al.
Gepubliceerd in: (1998)

Factors influencing remission, relapse, renal failure and mortality in patients with systemic vasculitis
door: Luqmani, R, et al.
Gepubliceerd in: (2007)

Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis.
door: Walsh, M, et al.
Gepubliceerd in: (2011)

Validation of the Birmingham Vasculitis Activity Score (Version 3)
door: Mukhtyar, C, et al.
Gepubliceerd in: (2009)

Disease assessment in systemic vasculitis
door: Luqmani, R
Gepubliceerd in: (2004)

THE PROGNOSTIC VALUE OF THE BIRMINGHAM VASCULITIS ACTIVITY SCORE AND THE VASCULITIS DAMAGE INDEX IN ANCA-ASSOCIATED VASCULITIS
door: Suppiah, R, et al.
Gepubliceerd in: (2011)

Outcome in small-vessel systemic vasculitis.
door: Luqmani, R, et al.
Gepubliceerd in: (2006)

Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure
door: Robson, J, et al.
Gepubliceerd in: (2018)

Evaluation of vasculitis disease activity in Europe.
door: Luqmani, R
Gepubliceerd in: (2001)

Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure
door: Robson JC, et al.
Gepubliceerd in: (2018-01-01)

Current status of outcome measure development in vasculitis.
door: Merkel, P, et al.
Gepubliceerd in: (2014)

Validation of a new version of the Birmingbam vasculitis activity score
door: Mukhtyar, C, et al.
Gepubliceerd in: (2008)

Vasculitis: an update.
door: Luqmani, R
Gepubliceerd in: (2014)

Vasculitis: an update.
door: Luqmani, R
Gepubliceerd in: (2014)

A disease-specific patient-reported outcome for anti-neutrophil cytoplasmic antibody–associated vasculitis: scale structure and measurement properties of the anti-neutrophil cytoplasmic antibody-associated vasculitis patient-reported outcome measure
door: Robson, J, et al.
Gepubliceerd in: (2017)

Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index.
door: Suppiah, R, et al.
Gepubliceerd in: (2011)

Measurement of damage in systemic vasculitis: A comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index
door: Suppiah, R, et al.
Gepubliceerd in: (2010)

Discontinuation of therapies in vasculitis.
door: Luqmani, R
Gepubliceerd in: (2013)

Discontinuation of therapies in vasculitis.
door: Luqmani, R
Gepubliceerd in: (2013)

Discontinuation of therapies in vasculitis.
door: Luqmani, R
Gepubliceerd in: (2013)

CLASSIFICATION AND DIAGNOSIS OF VASCULITIS
door: Luqmani, R
Gepubliceerd in: (2012)

A disease-specific patient-reported outcome for ANCA associated vasculitis: scale structure and measurement properties of the AAV- PRO
door: Robson, J, et al.
Gepubliceerd in: (2017)

Pharmacotherapy of vasculitis.
door: Chan, M, et al.
Gepubliceerd in: (2009)

Scale Structure and Measurement Properties of a Disease Specific Patient-Reported Outcome for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
door: Robson, J, et al.
Gepubliceerd in: (2016)

MEASUREMENT OF DAMAGE IN SYSTEMIC VASCULITIS: A COMPARISON OF THE VASCULITIS DAMAGE INDEX (VDI) WITH THE COMBINED DAMAGE ASSESSMENT INDEX (CDA)
door: Suppiah, R, et al.
Gepubliceerd in: (2010)

276 The short-term damage burden in vasculitis and vasculitis mimics as measured by the vasculitis damage index
door: Floris, A, et al.
Gepubliceerd in: (2016)